Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
Clinical trial NCT06786299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06786299
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2026-10-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.